Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo.

Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo. Int J Cancer. 2010 Jun 15; 126(12):2893-903.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.